| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 08/31/2005 | CN1662239A Combination comprising a vasculostatic compound and an alkylating agent for the treatmemt of a tumor |
| 08/31/2005 | CN1662235A Use of MGLUR5 antagonists for the treatment of GERD |
| 08/31/2005 | CN1662234A Use of thio-oxindole derivatives in treatment of hormone-related conditions |
| 08/31/2005 | CN1662232A Medicinal compositions improving brain function and method for improving brain function |
| 08/31/2005 | CN1662231A Prevention and treatment of functional somatic disorders, including stress-related disorders |
| 08/31/2005 | CN1662229A Use of taurine for the treatment of alopecia |
| 08/31/2005 | CN1662228A Compositions and method for transmucosal drug delivery and cryoprotection |
| 08/31/2005 | CN1662213A Composition for enhancing oral health |
| 08/31/2005 | CN1662177A Appts. and method for shape aesthetics |
| 08/31/2005 | CN1662152A Nutritious compositions for detoxification and cancer prevention |
| 08/31/2005 | CN1662142A Oil body associated protein compositions, methods of and use thereof for reducing the risk of cardiovascular disease |
| 08/31/2005 | CN1661110A Novel targets for obesity from fat tissue |
| 08/31/2005 | CN1661109A Novel targets for obesity from skeletal muscle |
| 08/31/2005 | CN1660911A Connective tissue growth factor fragments and methods and uses thereof |
| 08/31/2005 | CN1660443A Application of ramification of methoxypolythylene glycol, chemical modified general type red blood cell and preparation method |
| 08/31/2005 | CN1660441A Transmission system of drug for nasal cavity of containing trehalose and byaluronic acid, and preparation method |
| 08/31/2005 | CN1660438A Slow released anticancer combination of medication embedded the interior of the body |
| 08/31/2005 | CN1660437A Combination of slow released anticancer medication |
| 08/31/2005 | CN1660436A Anticancer combination of medication |
| 08/31/2005 | CN1660435A New drug combinations |
| 08/31/2005 | CN1660434A Combination of medication for anti malignant tumours and application |
| 08/31/2005 | CN1660433A Combination of treating and/or preventing hemorrhoid |
| 08/31/2005 | CN1660432A Preparation of compound Tatin class and hepatic protectant and applications |
| 08/31/2005 | CN1660431A Combination of medication containing reductase inhibitor HMG CoA and Melatonin |
| 08/31/2005 | CN1660430A New application of angiogenesis inhibitor in use for treating hemorrhoid |
| 08/31/2005 | CN1660429A New application of inhibitor of matrix metal metal protease (MMP) in use for treating hemorrhoid |
| 08/31/2005 | CN1660428A New application of synthase inhibitor of nitric in use for treating hemorrhoid |
| 08/31/2005 | CN1660427A Extracorporeal photopheresis in combination with anti-tnf treatment |
| 08/31/2005 | CN1660426A Methods for inhibiting brain tumor growth |
| 08/31/2005 | CN1660355A Chinese materia medica preparation for treating wound, rheumatic bone ache and preparing method |
| 08/31/2005 | CN1660321A Medicinal preparation of extractive from compound aspirin and rice fermentred with red yeast |
| 08/31/2005 | CN1660131A Oral taking preparation for aesthetic health care and preparation method |
| 08/31/2005 | CN1660130A Human body lubricant of containing fucose and hyaluronic acid, and its prepn. method |
| 08/31/2005 | CN1660128A Application of chitosan and ramification in lkjpreparing product for anti Helicobacter Pylori |
| 08/31/2005 | CN1660111A Highly selective norepinephrine reuptake inhibitors and methods of using the same |
| 08/31/2005 | CN1660110A Highly selective norepinephrine reuptake inhibitors and methods of using the same |
| 08/31/2005 | CN1660109A Highly selective norepinephrine reuptake inhibitors and methods of using the same |
| 08/31/2005 | CN1660108A Highly selective norepinephrine reuptake inhibitors and methods of using the same |
| 08/31/2005 | CN1660083A Method of using benzenesulphoamides that are cyclooxygenase-2-inhibitors in the treatment and prevention of neoplasia |
| 08/31/2005 | CN1660081A Leather externally used paste |
| 08/31/2005 | CN1660060A Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of hyperuricemia |
| 08/31/2005 | CN1217190C Modulation of smrl-nep interactions in cns disorders giving rise to mental disorders |
| 08/31/2005 | CN1216873C Valsartan salts |
| 08/31/2005 | CN1216869C Polymorphic crystalline forms of celecoxib |
| 08/31/2005 | CN1216864C Positive modulators of nicotinic receptor agonists |
| 08/31/2005 | CN1216857C Aniline-derived ligands for thyroid receptor |
| 08/31/2005 | CN1216642C Anti-infective active substance combinations and use thereof for topical treatment of fungus diseases of toe and finger nails |
| 08/31/2005 | CN1216638C Genes coding proteins for early liver development and their use indiagnosing and treating liver disease |
| 08/31/2005 | CN1216605C Combination therapy for treatment of tumors |
| 08/31/2005 | CN1216598C 药物用途 Drug use |
| 08/30/2005 | US6936704 a nucleotide sequence which hybridizes to the complement of the specific nucleic acid molecule over its full length under conditions of incubation and encodes a polypeptide which costimulates T cell proliferation in vitro |
| 08/30/2005 | US6936627 treating/preventing gastrointestinal disorders, inflammations and microbial infections; improving gastroprotective properties of H2 receptor antagonists; decreasing the recurrence of ulcers; facilitating ulcer healing |
| 08/30/2005 | US6936601 Psychological disorders; synergistic mixture |
| 08/30/2005 | US6936590 Treating diabetic with a sodium dependent glucose transporters (SGLT2) inhibitors, especially type II diabetes; use of pyran compounds including dapaglifozin |
| 08/30/2005 | US6936589 Concurrent administering of druh and hypotonic sugar solution |
| 08/30/2005 | US6936583 coadministering a taxane and an oral bioavailability enhancing agent inhibitor of p-glycoprotein; preventing or reducing hypersensitivity or allergic reactions; anticancer agents |
| 08/30/2005 | US6936458 Isolated DNA comprising one or more genes specific for 5S clavam biosynthesis, vectors comprising such DNA and streptomyces hosts capable of improved clavulanic acid production |
| 08/30/2005 | US6936453 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof |
| 08/30/2005 | US6936452 Inhibitors of the inositol polyphosphate 5-phosphate SHIP2 molecule |
| 08/30/2005 | US6936424 Materials and methods for detection and treatment of breast cancer |
| 08/30/2005 | US6936276 For tissue regeneration, applying a multilayer biodegradable matrix of crosslinked proteins and/or polysaccharides, where each layer has porosity to accomodate living cells; bone, joint, cartilage repair |
| 08/30/2005 | US6936273 Treating lameness in horses with a topical nonsteroidal antiinflammatory formulation of diclofenac salt, propylene glycol, ethanol, vitamin E acetate, phospholipid, wherein vesicles or liposomes of the diclofenac salt are present |
| 08/30/2005 | US6936267 Anti-acne compositions and methods of use |
| 08/30/2005 | US6936261 Vaccines for broad spectrum protection against diseases caused by Neisseria meningitidis |
| 08/30/2005 | US6936253 Ganglioside-KLH conjugate vaccines plus QS-21 |
| 08/30/2005 | US6936248 Methods of inhibiting GPR-9-6 function |
| 08/30/2005 | US6936044 Method and apparatus for the stimulation of hair growth |
| 08/30/2005 | US6935334 Enhancing therapeutic effectiveness of nitric oxide inhalation |
| 08/30/2005 | US6935271 Method for producing a bovine teat dip |
| 08/30/2005 | CA2103887C Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
| 08/25/2005 | WO2005078072A1 Regulatory cell controlling immunological activity of t cell |
| 08/25/2005 | WO2005077905A1 Fused-ring 4-oxopyrimidine derivative |
| 08/25/2005 | WO2005077464A1 Alcohol metabolism moderating composition |
| 08/25/2005 | WO2005077418A1 Combination of renin inhibitor and diuretics |
| 08/25/2005 | WO2005077411A2 Composition and method for the treatment of carcinoma |
| 08/25/2005 | WO2005077405A1 Compositions and methods for the treatment of cancer by systemic elevation of lactate and consequent depletion of arginine |
| 08/25/2005 | WO2005077394A1 Compositions for treatment of cancer and inflammation with curcumin and at least one nsaid |
| 08/25/2005 | WO2005077386A1 Composition and method for use in cartilage affecting conditions |
| 08/25/2005 | WO2005077385A2 Methods for treating resistant or refractory tumors |
| 08/25/2005 | WO2005077383A1 The use of o-atp for the treatment of diseases involving angiogenesis |
| 08/25/2005 | WO2005077349A1 HUMAN β-DEFENSIN PRODUCTION ACCELERATOR |
| 08/25/2005 | WO2005077168A1 Method and compositions for treatment of painful disorders |
| 08/25/2005 | WO2005077005A2 Enhancing the effectiveness of an inhaled therapeutic gas |
| 08/25/2005 | WO2005076987A2 Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory agent |
| 08/25/2005 | WO2005076975A2 Complexed polypeptide and adjuvant for improved vaccines |
| 08/25/2005 | WO2005053739A3 Combination therapy |
| 08/25/2005 | WO2005049827B1 Ppmp as a ceramide catabolism inhibitor for cancer treatment |
| 08/25/2005 | WO2005044182A3 Compositions of botanical extracts for cancer therapy |
| 08/25/2005 | WO2004064844A9 Method for inhibition of necrosis induced by neurotrophin |
| 08/25/2005 | US20050187303 Therapeutic causing contraction of mucosal tissue, method of treating diseases relating to mucosal tissues, injector and therapeutic set |
| 08/25/2005 | US20050187290 administering vitamin C or derivatives, as cyclic adenosine monophosphate (cAMP) modulators; demyelination; Charcot-Marie-Tooth disease; genetic disorders |
| 08/25/2005 | US20050187285 administering anticholesterol agents to inhibit the induction of major histocompatibilty complex (MHC class II) expression by gamma-inteferon (IFN- gamma); treatment of autoimmune diseases |
| 08/25/2005 | US20050187273 Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 08/25/2005 | US20050187269 Benzimidazole derivative and use thereof |
| 08/25/2005 | US20050187262 Treating a cardiovascular disorder by administering a low dosage of enantiomerically pure (S)-amlodipine along with an angiotensin receptor blocker from the group of candesartan, eprosartan, telmisartan, irbesartan, pratosartan, valsartan or olmesartan; side effect reduction; hypotensive agents; angina |
| 08/25/2005 | US20050187261 For hepatitis C; histone deacetylase inhibitors, anticarcinogenic agents; N-hydroxy-4-{[(benzofuran-, benzothiophen-, or indol-)-2-ylcarbonylamino]alkoxy}benzamides; amidation of a benzoic acid, benzoate, benzoyl halide with hydroxyamine |
| 08/25/2005 | US20050187253 Medicinal kit to quit tobacco consumption comprising central cannabinoid receptor antagonist |
| 08/25/2005 | US20050187222 Therapy for impotency, erectile dysfuction; benign prostatic hyperplasia; hypotensive agents; congestive heart failure; vision defects; neurodegenerative disorders; incotinence; cognition activators |
| 08/25/2005 | US20050187220 Alleviating pain, treating a locomotive disorders, stress, depression, epilepsy, Alzheimer's disease, senile dementia, general cognitive dysfunction, drug and alcohol abuse, hypotension, hypertension, tinnitus, pruritus, defective hearing, anorexia, obesity; chemical synthesis |
| 08/25/2005 | US20050187215 synergistic mixture of certain previously disclosed cyclic ketoenols and agonists or antagonists of nicotinic acetylcholine receptors |